Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 8:37 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2329–2352 of 21,042 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: ONE Clear all

Conditions: CLL
Interventions: Ofatumumab/HDMP; Drug
Lead sponsor: Januario Castro, M.D.; Other
Eligibility: 18 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 2
States / cities: La Jolla, California

Conditions: Colorectal Cancer
Interventions: Racial group-targeted messages, Explicit Commitment; Other
Lead sponsor: Oakland University; Other
Eligibility: 45 Years to 80 Years
Enrollment: 799 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Rochester, Michigan

Conditions: Healthy
Interventions: Ad26.Mos.HIV, Clade C gp140, Placebo; Biological · Drug
Lead sponsor: Janssen Vaccines & Prevention B.V.; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Hypoxic-Ischemic Encephalopathy, Brain Ischemia Hypoxia
Interventions: Sulfur hexafluoride lipid-type A microspheres; Drug
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 1 Minute to 18 Months
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Breast Cancer
Interventions: Acupuncture, Sham Acupuncture, Wait-List Control (WLC), Questionnaires; Procedure · Other
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 270 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 7
States / cities: Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more

Conditions: Chronic Myelogenous Leukemia - Chronic Phase
Interventions: Nilotinib; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 11
States / cities: Los Angeles, California • Augusta, Georgia • Beech Grove, Indiana + 8 more

Conditions: Multiple Sclerosis
Interventions: Active tDCS; Device
Lead sponsor: NYU Langone Health; Other
Eligibility: 23 Years to 59 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Memory Disorders, Cognitive Impairment
Interventions: Self-Guided, Structured Group; Behavioral
Lead sponsor: University of California, Davis; Other
Eligibility: 65 Years to 90 Years
Enrollment: 263 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Chronic Pain, Cesarean Section Complications
Interventions: Empowered Relief; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Mastectomy, Mammaplasty, Breast Reconstruction
Interventions: REVOLVE Advanced Adipose System, LipoGrafter, Viality; Device · Procedure
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 135 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: Autonomic Dysfunction, Orthostatic Intolerance
Interventions: Development of AD/OI after BS; Other
Lead sponsor: Kansas City Heart Rhythm Research Foundation; Other
Eligibility: 18 Years to 85 Years
Enrollment: 400 participants
Timeline: 2024 – 2025
U.S. locations: 8
States / cities: Overland Park, Kansas • Independence, Missouri • Kansas City, Missouri

Conditions: Stroke
Interventions: repetitive transcranial magnetic stimulation (rTMS), peripheral sensory stimulation; Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2022
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Diabetes
Interventions: Bayer G3 / Tatsu System, Accu-Chek® Aviva Nano Meter/Accu-Chek® Aviva Test Strips, Freestyle Lite® Meter and Test Strips with ZipwikTM tabs, OneTouch® Ultra®2 / OneTouch® Ultra® Blue Test Strips, One Touch® VerioTM Pro/One Touch® VerioTM Test Strips, Truetrack® Meter/Truetrack® Test Strips; Device
Lead sponsor: Ascensia Diabetes Care; Industry
Eligibility: 18 Years and older
Enrollment: 146 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012
U.S. locations: 1
States / cities: Renton, Washington

Conditions: IBS (Irritable Bowel Syndrome)
Interventions: Inulin, Low-fiber control breakfast shake, Atmo Gas-Sensing Capsule, CapScan Regional Fluid-Sampling Capsule; Dietary Supplement · Other · Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Stanford, California

Conditions: Burnout, Professional, Anxiety, Depression, Stress
Interventions: RISE yoga-based program; Behavioral
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 56 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Panniculectomy, Abdominoplasty
Interventions: Tranexamic acid, Saline; Drug
Lead sponsor: The Reading Hospital and Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: West Reading, Pennsylvania

Conditions: Persistent Atrial Fibrillation
Interventions: Catheter Ablation; Procedure
Lead sponsor: Stavros E Mountantonakis; Other
Eligibility: 18 Years to 80 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 3
States / cities: Manhasset, New York • New Hyde Park, New York • New York, New York

Conditions: Perceptions
Interventions: CBD advertisements; Behavioral
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years to 65 Years
Enrollment: 3,504 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Urothelial Carcinoma, Renal Cell Carcinoma, Non-Small Cell Lung Cancer, Castration-resistant Prostate Cancer, Triple Negative Breast Cancer, Ovarian Cancer, Endometrial Cancer, Hepatocellular Carcinoma, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Colorectal Cancer, Head and Neck Cancer, Differentiated Thyroid Cancer, Lower Esophageal Cancer
Interventions: cabozantinib, atezolizumab; Drug
Lead sponsor: Exelixis; Industry
Eligibility: 18 Years and older
Enrollment: 914 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2027
U.S. locations: 57
States / cities: Gilbert, Arizona • Phoenix, Arizona • Duarte, California + 45 more

Conditions: Menopause
Interventions: estrogen patch, Amino acids, Placebo Patch, Placebo pills; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 48 Years to 60 Years · Female only
Enrollment: 47 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2018
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Healthy
Interventions: Topical Myristyl Nicotinate Cream, Placebo; Drug
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years and older
Enrollment: 22 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Hypoxic-Ischemic Encephalopathy, Neonatal Encephalopathy, Encephalopathy
Interventions: Visual Evoked Potential (VEP), Electroretinogram (ERG); Device
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: Up to 36 Months
Enrollment: 125 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2029
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Opioid Use Disorder, Cannabis Use
Interventions: Cannabis, Placebo Cannabis, Intranasal Opioid Agonist, Oral Opioid Agonist; Drug
Lead sponsor: Shanna Babalonis, PhD; Other
Eligibility: 18 Years to 55 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Adolescent Idiopathic Scoliosis (AIS)
Interventions: Dexamethasone postoperative, Standard of Care; Drug
Lead sponsor: Emory University; Other
Eligibility: 10 Years to 18 Years
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Atlanta, Georgia

Search by objective public record fields.

Ofatumumab and High-dose Methylprednisolone in Patients With Chronic Lymphocytic Leukemia (CLL)

Colorectal Cancer Screening Intervention Study

Safety, Tolerability and Immunogenicity Study of Different Vaccine Schedules With Ad26.Mos.HIV and Clade C Glycoprotein (gp)140 in Healthy Human Immunodeficiency Virus (HIV)-Uninfected Adults

CEUS Evaluation of Hypoxic Ischemic Injury

The Effect of Acupuncture on Cancer-Related Cognitive Difficulties

Study of Molecular Response in Adult Patients on Nilotinib With Philadelphia Chromosome Positive Chronic Myelogenous Leukemia (Ph+ CML) in Chronic Phase and a Suboptimal Molecular Response to Imatinib

Cognitive Markers in Prodromal MS

Brain Boosters 2 in Persons at Risk for Alzheimer's Disease: a Digital Application Supported Intervention

Empowered Relief: A One-Time Session to Help Postpartum Women Manage Ongoing Pain After Cesarean Delivery

A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery

Autonomic Dysfunction in Patients Following Bariatric Surgery: The ADiPOSE Study

Can rTMS Enhance Somatosensory Recovery After Stroke?

Comparison Evaluation of Blood Glucose Meter Systems in a Clinical Setting

High-Resolution Measurements of Diet-Microbiome Interactions

Feasibility of a Yoga- and Mindfulness-Based Intervention for Resident Physicians

TXA in the Reduction of Post-Op Hematoma and Seroma in Patients Undergoing Panniculectomy or Abdominoplasty

ARIADNE Clinical Trial

Consumer Perceptions of Cannabidiol (CBD) Health Claims

Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors

Estrogen and Serotonin on Changing Brain Chemistry

Topical Myristyl Nicotinate Cream on the Skin of Healthy Volunteers

Healthy Little Eyes

Cannabis Effects on Opioid Self-Administration

Perioperative Steroid Dosing on the APR in AIS